Chembio Diagnostics develops, manufactures, markets, and licenses rapid point-of-care (POC) diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV and syphilis antibodies. The Company's products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV 1/2 Assay Test, a DPP HIV-Syphilis multiplex test, and a test for the detection of Hepatitis-C. Chembio Diagnostics sells its products under a number of brands and labels. The Company has collaboration agreements to develop POC diagnostic tests for traumatic brain injury, a specific type of cancer and an undisclosed biomarker.

Employee Rating

2.0More
TypePublic
HQMedford, US
Founded1985
Size (employees)131 (est)
Websitechembio.com
Chembio was founded in 1985 and is headquartered in Medford, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Chembio

John Sperzel

John Sperzel

President and Chief Executive Officer

Chembio Office Locations

Chembio has an office in Medford
Medford, US (HQ)
3661 Horseblock Road
Show all (1)
Report incorrect company information

Chembio Financials and Metrics

Chembio Revenue

Embed Graph
View revenue for all periods
Chembio's revenue was reported to be $24.02 m in FY, 2017
USD

Revenue (Q3, 2018)

9.4m

Gross profit (Q3, 2018)

2.6m

Gross profit margin (Q3, 2018), %

27.7%

Net income (Q3, 2018)

(2.3m)

EBIT (Q3, 2018)

(2.3m)

Market capitalization (17-Jan-2019)

121.2m

Closing stock price (17-Jan-2019)

7.1

Cash (30-Sep-2018)

6.8m

EV

114.7m
Chembio's current market capitalization is $121.2 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

29.5m27.6m24.3m13.7m24.0m

Revenue growth, %

(6%)(12%)(26%)

Cost of goods sold

17.2m16.8m13.8m9.4m12.9m

Gross profit

12.3m10.8m10.5m4.3m11.1m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

9.6m5.8m7.4m7.3m6.2m6.7m6.9m6.6m3.3m3.7m6.3m4.1m7.6m7.7m8.7m9.4m

Cost of goods sold

5.6m3.5m4.4m4.7m3.5m3.7m4.0m3.4m1.7m1.8m3.2m2.2m4.1m4.1m5.9m6.8m

Gross profit

4.1m2.3m3.0m2.7m2.7m3.0m2.9m3.2m1.6m2.0m3.1m1.9m3.5m3.6m2.8m2.6m

Gross profit Margin, %

42%39%40%36%43%45%42%48%48%52%49%46%46%47%32%28%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

9.7m4.6m5.4m10.6m3.8m

Accounts Receivable

525.6m

Inventories

3.2m3.6m3.6m3.3m4.4m

Current Assets

18.5m17.7m12.6m18.1m10.9m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

8.0m9.1m6.8m3.7m2.8m1.6m1.1m2.7m1.4m12.2m5.6m3.7m1.9m12.5m9.5m6.8m

Inventories

3.7m3.6m4.1m4.0m3.7m3.8m3.0m3.4m3.5m3.4m3.8m5.0m5.2m5.8m6.3m6.0m

Current Assets

18.0m17.2m17.5m17.0m16.2m15.7m15.2m12.0m10.4m20.6m15.9m14.1m13.7m22.9m23.5m22.2m

PP&E

1.8m1.9m2.1m2.1m3.0m2.8m2.6m2.2m2.0m1.8m1.9m2.1m2.0m1.9m2.4m2.4m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

530.8k(1.1m)(2.4m)(13.3m)(6.4m)

Depreciation and Amortization

607.8k739.3k1.4m1.1m1.3m

Inventories

(700.7k)(449.6k)60.3k242.8k(1.1m)

Accounts Payable

1.0m(2.1m)211.7k182.5k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

792.8k(224.7k)(370.7k)(641.3k)(303.6k)(8.3m)(2.1m)(1.6m)(3.8m)(4.4m)(652.3k)(2.4m)(4.7m)

Depreciation and Amortization

446.2k172.7k343.8k536.8k665.7k981.6k291.6k477.8k773.6k1.0m223.0k446.6k663.3k

Inventories

(1.3m)(415.9k)(890.5k)(786.5k)3.7m(143.4k)627.8k194.8k3.5m3.4m(419.3k)(1.7m)(1.9m)(1.4m)(1.9m)(1.6m)

Accounts Payable

631.1k(1.0m)(513.6k)(490.2k)(204.8k)(494.3k)(385.3k)237.0k542.8k657.7k1.3m3.0m3.8m
USDY, 2018

EV/EBIT

-49.2 x

EV/CFO

-15.2 x

Financial Leverage

1.4 x
Show all financial metrics

Chembio Operating Metrics

FY, 2016

Patents (US)

4

Products

3
Show all operating metrics

Chembio Revenue Breakdown

Embed Graph

Chembio revenue breakdown by geographic segment: 35.6% from South America, 37.2% from North America, 8.3% from Europe, 17.3% from Africa and 1.7% from Other

Report incorrect company information

Chembio Online and Social Media Presence

Embed Graph
Report incorrect company information

Chembio News and Updates

Chembio to Participate in Upcoming Investor Conferences

MEDFORD, N.Y., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today announced plans to participate in two upcoming investor conferences. 

Chembio Diagnostics Announces Pricing of its Public Offering of Common Stock

MEDFORD, N.Y., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI) (“Chembio”), a provider of point-of-care diagnostic tests for infectious diseases, announced today the pricing of its previously announced underwritten registered public offering of 2,370,435 shares of its co…

Chembio Announces Proposed Public Offering of Common Stock

MEDFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio” or the “Company”), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it has commenced an underwritten public offering of $25 million of its common sto…

Chembio Receives $10.5 Million Commitment from Bio-Manguinhos for Production of DPP® Assays in Brazil

MEDFORD, N.Y., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has received a $10.5 million commitment from Bio-Manguinhos to purchase test components and intermediate prod…

Chembio Diagnostics Reports Second Quarter 2018 Financial Results

MEDFORD, N.Y., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic testing, today reported financial results for the second quarter ended June 30, 2018.
Show more
Report incorrect company information

Chembio Blogs

Formulations Lab Supervisor

Job Title: Formulations Lab Supervisor Department: Formulations Department Reports To: Chief Operating Officer Pay Classification: Exempt Position Summary: The Formulations Lab Supervisor is responsible for the direct supervision of all formulation and processing of Antibody Reagents and Diluent…

Buyer/Planner- Supply Chain

Job Title: Buyer/Planner- Supply Chain Department: Operations Reports To: Vice President, Manufacturing Operations Pay Classification: Exempt Position Summary: The Buyer/Planner is responsible for purchasing merchandise, materials, components, equipment, and/or services; perform a variety of pro…

Automation Engineer

Job Title: Automation Engineer Department: Manufacturing Engineering – Operation Group. Reports To: Senior Engineering Manager Responsibilities include but are not limited to: A motivated automation engineer, who can develop concepts and specifications for complex electro-mechanical assembly and…

Laboratory Analyst

Job Title: Laboratory Analyst Department: Quality Control Reports To: Quality Control Manager Pay Classification: Non-Exempt, Hourly Position Summary: Responsible for participating in the management and maintenance of the Quality System and related documents and processes. Duties & Responsib…

Machine Maintenance Mechanic (Level II)

Job Title: Machine Maintenance Mechanic (Level II) Department: Maintenance Reports To: Sr. Manager, Facilities & Maintenance Pay Classification: Hourly Position Summary: Machine Maintenance Mechanic (Level II) will perform a wide range of operations associated with the maintenance, repair, …

Machine Maintenance Mechanic (Level I)

Job Title: Machine Maintenance Mechanic (Level I) Department: Maintenance Reports To: Sr. Manager, Facilities & Maintenance Pay Classification: Hourly Position Summary: The Machine Maintenance Mechanic (Level I) will perform a wide range of operations associated with the maintenance, repair…
Show more

Chembio Company Life and Culture

Report incorrect company information

Chembio Frequently Asked Questions

  • When was Chembio founded?

    Chembio was founded in 1985.

  • Who are Chembio key executives?

    Chembio's key executives are John Sperzel.

  • How many employees does Chembio have?

    Chembio has 131 employees.

  • What is Chembio revenue?

    Latest Chembio annual revenue is $24 m.

  • What is Chembio revenue per employee?

    Latest Chembio revenue per employee is $183.3 k.

  • Who are Chembio competitors?

    Competitors of Chembio include Varex Imaging, SeLux Diagnostics and Immunovia.

  • Where is Chembio headquarters?

    Chembio headquarters is located at 3661 Horseblock Road, Medford.

  • Where are Chembio offices?

    Chembio has an office in Medford.

  • How many offices does Chembio have?

    Chembio has 1 office.